ArticleEuropean journal of applied physiology2025
Is soleus intrinsic motor neuron excitability contributing to motor deficits in runners with Achilles tendinopathy?
Article in European journal of applied physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSoleus weakness is suggested to contribute to Achilles tendinopathy (AT) in runners. Since muscle force relies on the ability of motor units firing at high frequencies, and intrinsic motor neuron excitability contributes to firing rate modulation, soleus inhibition and hypoexcitability may contribute to AT soleus weakness. This study investigated soleus motor neuron excitability by comparing: (i) estimates of persistent inward currents (Δf and Δf/k), which is known to modulate excitability; (ii) brace height, which is related to neuromodulatory input onto motor neurons; (iii) attenuation slopes, which estimate the influence of inhibitory input onto the motor units; and (iv) and motor unit firing rates between runners with and without mid-portion AT.
methodsDelta frequency absolute and normalized (ΔF and ΔF/k), brace height, attenuation slope, and peak firing rates were compared between runners with AT (n = 11) and without AT (n = 12). These variables were calculated from ramp triangular-shaped isometric plantar flexor contractions at 20% maximal torque. Soleus motor unit firing rates were assessed using high-density surface electromyography.
resultsNo significant differences were found between groups in soleus ΔF (estimated mean difference: - 0.1 pps; 95% CI: - 1.3 to 1.0; p = 0.79), ΔF/k (0.2 pps; - 0.03 to 0.3; p = 0.09), brace height (- 3.9% rTri; - 8.3 to 0.4; p = 0.07), attenuation (0.04 pps/% torque; - 0.04 to 0.1; p = 0.27), or peak firing rates (- 0.4 pps; - 1.6 to 0.9; p = 0.55).
conclusionSoleus motor neuron excitability or firing rates may not contribute to plantar flexor weakness in AT. Future studies should investigate other neurophysiological mechanisms and gastrocnemius contributions to AT-related weakness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.